B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling

REACTOME PATHWAY
Reactome: R-HSA-9751104 genes17 compounds

The TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling pathway (Reactome ID: R-HSA-975110) involves 4 genes and is affected by 17 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

IRAK1IRAK4TLR9UBE2N

Compounds Affecting TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling

#CompoundTargets HitStudies
1naringin300
2Chlorhexidine299
3Perphenazine297
4Sphingosine300
5Resveratrol298
6Sertraline1,000
7Astemizole Antihistamine drug now withdrawn from280
8Canrenone300
9Thioridazine35
10Crizotinib298
11Afatinib297
12alsterpaullone12
13Axitinib298
14Sorafenib300
15Dasatinib299
16sp600125117
17Oxyphenbutazone300

About the TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling Pathway

The TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling pathway is catalogued in Reactome (ID: R-HSA-975110) and involves 4 genes. In the BiohacksAI corpus, 17 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include IRAK1, IRAK4, TLR9, UBE2N.